Skip to main content
DreamCIS INC. logo

DreamCIS INC. — Investor Relations & Filings

Ticker · 223250 ISIN · KR7223250002 KO Professional, scientific and technical activities
Open in API
Filings indexed 197 across all filing types
Latest filing 2026-05-14 Interim / Quarterly Rep…
Country KR South Korea
Listing KO 223250

About DreamCIS INC.

https://dreamcis.com/

DreamCIS INC. is a contract research organization (CRO) that provides comprehensive clinical research services to the pharmaceutical, biotechnology, and medical device industries. The company's offerings cover the full lifecycle of clinical development, including project management, biostatistics, and data management for clinical trials and post-marketing surveillance. DreamCIS specializes in a wide range of therapeutic areas, with extensive experience in oncology, cardiovascular diseases, endocrinology, and rare diseases. In addition to full-service clinical development, the company also provides standalone services, dedicated support for medical device trials, and strategic consulting to guide clients through complex regulatory and development processes.

Recent filings

Filing Released Lang Actions
분기보고서 (2026.03)
Interim / Quarterly Report Classification · 95% confidence The document is titled “분기보고서” (Quarterly Report) covering the period 2026-01-01 to 2026-03-31 (first quarter of fiscal year 2026) and contains actual financial, operational, and governance details. It is a full interim/quarterly report, not just an earnings release or announcement. Therefore, it fits the Interim / Quarterly Report category. Q1 2026
2026-05-14 Korean
소속부변경
Regulatory Filings Classification · 95% confidence The document is a short announcement about a change in the company's department affiliation from '중견기업부' (Mid-sized Enterprise Division) to '벤처기업부' (Venture Enterprise Division). It includes the company name, the change details, the reason for the change, and the effective date. There is no financial data, no mention of reports, no regulatory certifications, or voting results. This type of announcement fits best under Regulatory Filings (RNS) as it is a general regulatory announcement that does not fit other specific categories.
2026-04-30 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 90% confidence The document is titled “임원ㆍ주요주주 특정증권등 소유상황보고서” and details an executive’s shareholdings and transactions (acquisitions of ordinary shares) filed with the Securities and Futures Commission and KRX. This is a regulatory insider‐trading/ownership report by a company director, matching the “Director’s Dealing” category.
2026-04-06 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a formal report of the resolutions and voting outcomes from the company’s regular annual general shareholders’ meeting held on March 31, 2026. It details items approved (financial statements, board and auditor appointments), vote counts and percentages, and related meeting procedural details. This clearly aligns with “Declaration of Voting Results & Voting Rights Announcements.”
2026-03-31 Korean
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Board/Management Information Classification · 85% confidence The document is a formal notice to the Financial Services Commission/Korea Exchange regarding the appointment, reappointment, dismissal, and mid-term retirement of outside directors (‘사외이사 선임·해임·중도퇴임’). This clearly relates to changes in the company’s board of directors. It is not an earnings release, annual report, or proxy statement, but rather a specific board/management change announcement. Therefore, it fits the Board/Management Information category (Code: MANG).
2026-03-31 Korean
파생상품거래손실발생
Regulatory Filings Classification · 82% confidence The document is a regulatory disclosure of a derivative trading loss that the company is required to file with the stock exchange. It lists the type of derivative, loss amounts, ratio to equity, reasons, loss date, and related notice links. It is not a full financial report (10-K or interim) nor an audit report, earnings release, management change, or other specialized category. Therefore, it falls under the fallback category for general regulatory announcements (RNS).
2026-03-24 Korean

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.